THERAPEUTIC AGENT FOR ENDOTHELIAL DYSFUNCTION CORRECTION

摘要

FIELD: medicine, pharmaceutics.;SUBSTANCE: invention refers to medicine, namely to pharmacology and cardiology, and concerns endothelial dysfunction correction. That is ensured by administering a therapeutic agent containing an activated-potentiated form of antibodies to the endothelial synthase of nitrogen oxide in a complex of an activated-potentiated form of antibodies to the C-terminal fragment of the AT₁ angiotensin II receptor.;EFFECT: administering this agent provides the effective endothelial dysfunction correction by the synergistic effect of its ingredients.;6 cl, 1 ex, 1 tbl